Literature DB >> 20629657

Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience.

Alexandra Stefanovic, Janet Davis, Timothy Murray, Arnold Markoe, Izidore S Lossos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20629657      PMCID： PMC2950220          DOI： 10.1111/j.1365-2141.2010.08321.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma.

Authors:  L N Freeman; A P Schachat; D L Knox; R G Michels; W R Green
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

2.  Treatment for primary CNS lymphoma: the next step.

Authors:  L E Abrey; J Yahalom; L M DeAngelis
Journal:  J Clin Oncol       Date:  2000-09       Impact factor: 44.544

3.  Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.

Authors:  E K Akpek; I Ahmed; F H Hochberg; M Soheilian; T P Dryja; F A Jakobiec; C S Foster
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

4.  Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.

Authors:  Kristoph Jahnke; Agnieszka Korfel; Julia Komm; Nikolaos E Bechrakis; Harald Stein; Eckhard Thiel; Sarah E Coupland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-16       Impact factor: 3.117

5.  High-dose methotrexate for intraocular lymphoma.

Authors:  Tracy T Batchelor; Gina Kolak; Roberto Ciordia; C Stephen Foster; John W Henson
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

6.  The clinical spectrum of ocular lymphoma.

Authors:  K Peterson; K B Gordon; M H Heinemann; L M DeAngelis
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

7.  Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

Authors:  S A Grimm; J S Pulido; K Jahnke; D Schiff; A J Hall; T N Shenkier; T Siegal; N D Doolittle; T Batchelor; U Herrlinger; E A Neuwelt; N Laperriere; M C Chamberlain; J Y Blay; A J M Ferreri; A M P Omuro; E Thiel; L E Abrey
Journal:  Ann Oncol       Date:  2007-09-05       Impact factor: 32.976

8.  Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.

Authors:  Adília Hormigo; Lauren Abrey; Murk-Hein Heinemann; Lisa M DeAngelis
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

9.  The role of radiation therapy in the management of ocular reticulum cell sarcoma.

Authors:  L Margolis; R Fraser; A Lichter; D H Char
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860

10.  Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.

Authors:  P M Hoffman; P McKelvie; A J Hall; R J Stawell; J D Santamaria
Journal:  Eye (Lond)       Date:  2003-05       Impact factor: 3.775
  10 in total
  12 in total

1.  Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy.

Authors:  James L Rubenstein; Patrick A Treseler; Paul J Stewart
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

Review 2.  New approaches in primary central nervous system lymphoma.

Authors:  Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal:  Chin Clin Oncol       Date:  2015-03

3.  Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma.

Authors:  Chan Yoon Cheah; Sarah Milgrom; Dai Chihara; Dan S Gombos; Chelsea C Pinnix; Bouthaina S Dabaja; Nathan H Fowler
Journal:  Neuro Oncol       Date:  2015-10-20       Impact factor: 12.300

Review 4.  The Challenge of Primary Central Nervous System Lymphoma.

Authors:  Julia Carnevale; James L Rubenstein
Journal:  Hematol Oncol Clin North Am       Date:  2016-12       Impact factor: 3.722

Review 5.  Molecular pathology of lymphoma.

Authors:  S E Coupland
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

6.  How I treat CNS lymphomas.

Authors:  James L Rubenstein; Neel K Gupta; Gabriel N Mannis; Amanda K Lamarre; Patrick Treseler
Journal:  Blood       Date:  2013-08-20       Impact factor: 22.113

Review 7.  Progress in central nervous system lymphomas.

Authors:  Chia-Ching Wang; Julia Carnevale; James L Rubenstein
Journal:  Br J Haematol       Date:  2014-05-16       Impact factor: 6.998

Review 8.  Intraocular lymphoma: a clinical perspective.

Authors:  J L Davis
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

9.  High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma.

Authors:  Hiroki Akiyama; Hiroshi Takase; Fumito Kubo; Tohru Miki; Masahide Yamamoto; Makoto Tomita; Manabu Mochizuki; Osamu Miura; Ayako Arai
Journal:  Cancer Sci       Date:  2016-09-01       Impact factor: 6.716

Review 10.  Evaluation, Identification, and Management of Acute Methotrexate Toxicity in High-dose Methotrexate Administration in Hematologic Malignancies.

Authors:  Doron Feinsilber; Roberto J Leoni; Duminda Siripala; Julianne Leuck; Katrina A Mears
Journal:  Cureus       Date:  2018-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.